Similar articles

• Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee.

  Coyle D, Drummond MF. Coyle D, et al. Clin Oncol (R Coll Radiol). 1997;9(5):313-21. doi: 10.1016/s0936-6555(05)80065-2. Clin Oncol (R Coll Radiol). 1997. PMID: 9368727 Clinical Trial.
• Quality assurance in the CHART clinical trial.

  Aird EG, Williams C, Mott GT, Dische S, Saunders MI. Aird EG, et al. Radiother Oncol. 1995 Sep;36(3):235-44. doi: 10.1016/0167-8140(95)01598-b. Radiother Oncol. 1995. PMID: 8532912
• Radiotherapy employing three fractions on each of twelve consecutive days.

  Saunders MI, Dische S, Fowler JF, Denekamp J, Dunphy EP, Grosch E, Fermont D, Ashford R, Maher J, Des Rochers C. Saunders MI, et al. Acta Oncol. 1988;27(2):163-7. doi: 10.3109/02841868809090336. Acta Oncol. 1988. PMID: 3390346
• The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART).

  Dische S, Saunders MI. Dische S, et al. Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1317-20. doi: 10.1016/0360-3016(90)90251-e. Int J Radiat Oncol Biol Phys. 1990. PMID: 2254131 Review.
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

  Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maître A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP; Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Bourhis J, et al. Lancet. 2006 Sep 2;368(9538):843-54. doi: 10.1016/S0140-6736(06)69121-6. Lancet. 2006. PMID: 16950362 Review.